Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999WO1999050295A2 Agouti-related protein analogs and methods of use
10/07/1999WO1999050294A1 Novel hemolytic active proteins and genes encoding the same
10/07/1999WO1999050291A1 Retrovirus envelope gylcoprotein mutants and biological applications
10/07/1999WO1999050290A1 Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)
10/07/1999WO1999050289A2 Transformation progression-related genes and their use
10/07/1999WO1999050288A2 Mammalian blood loss-induced gene, kd312
10/07/1999WO1999050287A2 P40 protein acts as an oncogene
10/07/1999WO1999050286A2 Antioxidant peptides derived from apolipoprotein a-iv
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050282A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999WO1999050280A1 Compositions and methods for controlling brca1-mediated p53-dependent and -independent regulation of transcription
10/07/1999WO1999050279A1 Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
10/07/1999WO1999049909A2 Revascularization apparatus having coaxial channeling and injecting means
10/07/1999WO1999049898A1 Progression elevated gene-3 and uses thereof
10/07/1999WO1999049897A1 Hemoglobin-polysaccharide conjugates
10/07/1999WO1999049893A1 Methods for designing molecular conjugates and compositions thereof
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999049891A1 Compositions and methods for providing a vpr-binding protein to a virion
10/07/1999WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999WO1999049886A1 Compositions containing bactericides and digestive enzymes compositions
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049884A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999WO1999049883A2 Oxidized thymosin beta 4
10/07/1999WO1999049882A2 Vegf and vegf-c as infant formula supplements
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049879A1 Sequence and method for genetic engineering of proteins with cell membrane translocating activity
10/07/1999WO1999049860A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049840A1 Skin treatment compositions and the use thereof
10/07/1999WO1999049803A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999049732A1 Immune cell regulation with src ptk sequestering agents
10/07/1999WO1999049727A1 Antimicrobial protein compounds as novel oral hyperthermic agents for control of body weight and hypertension
10/07/1999WO1999042575A3 Calcium-activated potassium channel beta subunit gene and protein
10/07/1999WO1999041614A3 Method for detecting intimin producing microorganisms
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999040109A3 Recombinant mistletoe lectines
10/07/1999WO1999038888A3 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
10/07/1999WO1999037776A9 Methods for modulating angiogenesis
10/07/1999WO1999035169A3 Methods and compositions for treating and diagnosing insulin related disorders
10/07/1999WO1999032509A3 Hemiasterlin analogs
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999WO1999028461A3 Methods and means for inducing apoptosis by interfering with bip-like proteins
10/07/1999WO1999023221A3 Multivalent antigen-binding proteins
10/07/1999WO1999021996A9 Methods and compositions for the diagnosis and treatment of cataracts
10/07/1999DE19914474A1 New peptide aldehyde and boronic acid derivatives are proteinase inhibitors useful for treatment of viral infections, especially hepatitis
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999DE19814861A1 Neue Proteinvariante des NET1-Locus New protein variant of NET1 locus
10/07/1999DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
10/07/1999DE19812941A1 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor Medicines used to prevent or treat Papillomavirusspezifischem tumor
10/07/1999DE19812940A1 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung Formulation with papillomavirus-specific protein, its preparation and use
10/07/1999DE19810515A1 Composition containing stimulators of cyclic nucleotide monophosphate
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2401916A1 Recombinant anti-tumor rnase
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2331601A1 Vegf and vegf-c as infant formula supplements
10/07/1999CA2327388A1 Retrovirus envelope gylcoprotein mutants and biological applications
10/07/1999CA2326771A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999CA2326634A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999CA2326000A1 Gpi-122, a novel glycophosphatidylinositol-anchored protein
10/07/1999CA2325984A1 Oxidized thymosin beta 4
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324646A1 Recombinant anti-tumor rnase
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324511A1 Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999CA2324492A1 Secreted proteins and polynucleotides encoding them
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324445A1 Blk genes, gene products and uses thereof in apoptosis
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/07/1999CA2323773A1 Molecular sensing apparatus and method
10/07/1999CA2323748A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999CA2320491A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947524A1 Novel peptides for the treatment of autoimmune diseases
10/06/1999EP0947201A1 Pharmaceutical composition of hedgehog proteins and use thereof
10/06/1999EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999EP0946880A1 Method for diagnosis and therapy of hodgkin lymphomas
10/06/1999EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999EP0946736A1 Method for expression of heterologous proteins in yeast
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946730A2 Mutants of streptococcal toxin c and methods of use
10/06/1999EP0946728A1 Bone stimulating factor
10/06/1999EP0946727A1 Antibody mutants
1 ... 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 ... 3163